Regulation of cerebral CYP2D alters tramadol metabolism in the brain: interactions of tramadol with propranolol and nicotine
Authors:
- Xiaotong HanXHXiaotong Han
- Jian LiJLJian Li
- Xinghui GaoXGXinghui Gao
- Yan WangYWYan Wang
- Mingzhou LiuMLMingzhou Liu
- Guicheng DongGDGuicheng Dong
- Jiang YueJYJiang Yue
- 28 October 2014
- journal article
- Published by Taylor & Francis in Xenobiotica
- Vol. 45 (4) , 335-344
Abstract
1. Cytochrome P450 2D (CYP2D) protein is widely expressed across brain regions in human and rodents. We investigated the interactions between tramadol, a clinically used analgesic, and brain CYP2D regulators, by establishing concentration-time curves of tramadol and O-desmethyltramadol (M1) in rat cerebrospinal fluid (CSF) and plasma, as well as by analyzing the analgesia-time course of tramadol. 2. Propranolol (20 μg, intracerebroventricular injection), CYP2D inhibitor, prolonged the elimination t1/2 of tramadol (40 mg/kg, intraperitoneal injection) in the CSF; meanwhile, lower Cmax and AUC0-∞ values of M1 were observed. Nicotine (1 mg base/kg, subcutaneous injection, seven days), brain CYP2D inducer, induced a shorter Tmax and elevated Cmax of M1 in CSF. No differences in the peripheral metabolism of tramadol were observed following propranolol and nicotine pretreatment. Nicotine increased areas under the analgesia-time curve (AUC) for 0-45 min and 0-90 min of tramadol, which was attenuated by propranolol administration. The analgesic actions of tramadol positively correlated with cerebral M1 concentration. 3. The results suggest that the regulation of brain CYP2D by xenobiotics may cause drug-drug interactions (DDIs) of tramadol. Brain CYPs may play an important role in DDIs of centrally active substances.Keywords
This publication has 38 references indexed in Scilit:
- Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapyInternational Review of Psychiatry, 2013
- Cytochrome P450 enzymes in the brain: emerging evidence of biological significanceTrends in Pharmacological Sciences, 2011
- Effect of metamizol on morphine pharmacokinetics and pharmacodynamics after acute and subchronic administration in arthritic ratsEuropean Journal of Pharmacology, 2010
- ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disordersExpert Opinion on Drug Metabolism & Toxicology, 2010
- Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral FunctionDrug Metabolism and Disposition, 2009
- CYTOCHROME P450 AND XENOBIOTIC RECEPTOR HUMANIZED MICEAnnual Review of Pharmacology and Toxicology, 2006
- ABCG2 PharmacogeneticsClinical Cancer Research, 2004
- Clinical Pharmacology of TramadolClinical Pharmacokinetics, 2004
- A postmarketing surveillance program to monitor Ultram® (tramadol hydrochloride) abuse in the United StatesDrug and Alcohol Dependence, 1999
- Tramadol revisitedBritish Journal of Anaesthesia, 1999